130 related articles for article (PubMed ID: 22301377)
1. Crossroads in the evaluation of paraoxonase 1 for protection against nerve agent and organophosphate toxicity.
Valiyaveettil M; Alamneh YA; Doctor BP; Nambiar MP
Toxicol Lett; 2012 Apr; 210(1):87-94. PubMed ID: 22301377
[TBL] [Abstract][Full Text] [Related]
2. Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs.
Valiyaveettil M; Alamneh Y; Rezk P; Biggemann L; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
Biochem Pharmacol; 2011 Mar; 81(6):800-9. PubMed ID: 21219877
[TBL] [Abstract][Full Text] [Related]
3. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1.
Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Doctor BP; Nambiar MP
Biochem Biophys Res Commun; 2010 Dec; 403(1):97-102. PubMed ID: 21040699
[TBL] [Abstract][Full Text] [Related]
4. Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs.
Valiyaveettil M; Alamneh Y; Rezk P; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
Toxicol Lett; 2011 May; 202(3):203-8. PubMed ID: 21329748
[TBL] [Abstract][Full Text] [Related]
5. In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates.
Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Farag HA; Agrawal P; Doctor BP; Nambiar MP
Toxicol In Vitro; 2011 Jun; 25(4):905-13. PubMed ID: 21382471
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines.
Curtin BF; Seetharam KI; Dhoieam P; Gordon RK; Doctor BP; Nambiar MP
J Cell Biochem; 2008 Apr; 103(5):1524-35. PubMed ID: 17879943
[TBL] [Abstract][Full Text] [Related]
7. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
[TBL] [Abstract][Full Text] [Related]
8. Assessing protection against OP pesticides and nerve agents provided by wild-type HuPON1 purified from Trichoplusia ni larvae or induced via adenoviral infection.
Hodgins SM; Kasten SA; Harrison J; Otto TC; Oliver ZP; Rezk P; Reeves TE; Chilukuri N; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):177-80. PubMed ID: 23123254
[TBL] [Abstract][Full Text] [Related]
9. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
[TBL] [Abstract][Full Text] [Related]
10. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
[TBL] [Abstract][Full Text] [Related]
11. [Human plasma paraoxonase (HuPON1): an anti-atherogenic enzyme with organophosphate hydrolase activity].
Josse D; Masson P
Ann Pharm Fr; 2001 Apr; 59(2):108-18. PubMed ID: 11320335
[TBL] [Abstract][Full Text] [Related]
12. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning.
Rochu D; Chabrière E; Masson P
Toxicology; 2007 Apr; 233(1-3):47-59. PubMed ID: 17007987
[TBL] [Abstract][Full Text] [Related]
13. Histone acetylase inhibitor trichostatin A induces acetylcholinesterase expression and protects against organophosphate exposure.
Curtin BF; Tetz LM; Compton JR; Doctor BP; Gordon RK; Nambiar MP
J Cell Biochem; 2005 Nov; 96(4):839-49. PubMed ID: 16149071
[TBL] [Abstract][Full Text] [Related]
14. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
[TBL] [Abstract][Full Text] [Related]
15. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.
Lenz DE; Yeung D; Smith JR; Sweeney RE; Lumley LA; Cerasoli DM
Toxicology; 2007 Apr; 233(1-3):31-9. PubMed ID: 17188793
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
[TBL] [Abstract][Full Text] [Related]
17. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity.
Costa LG; Cole TB; Vitalone A; Furlong CE
Clin Chim Acta; 2005 Feb; 352(1-2):37-47. PubMed ID: 15653099
[TBL] [Abstract][Full Text] [Related]
18. A fluorogenic substrate for detection of organophosphatase activity.
Soukharev S; Hammond DJ
Anal Biochem; 2004 Apr; 327(1):140-8. PubMed ID: 15033522
[TBL] [Abstract][Full Text] [Related]
19. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
[TBL] [Abstract][Full Text] [Related]
20. Refolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate Poisoning.
Bajaj P; Tripathy RK; Aggarwal G; Datusalia AK; Sharma SS; Pande AH
Appl Biochem Biotechnol; 2016 Sep; 180(1):165-76. PubMed ID: 27131877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
